1
0
0
News
4basebio announces the supply of its opDNA™ DNA ...Investegate
www.investegate.co.uk
— Dr Heikki Lanckriet, CEO at the Company, commented: "This is a major achievement for our company and is significant both in terms of product — Dr Heikki Lanckriet, CEO at the Company, commented: "This is a major achievement for our company and is significant both in terms of product ...
EQS-News: Epigenomics AG: Jochen Hummel für Heikki ...FinanzNachrichten.de
www.finanznachrichten.de
— EQS-News: Epigenomics AG / Schlagwort(e): Personalie Epigenomics AG: Jochen Hummel für Heikki Lanckriet in den Aufsichtsrat bestellt — EQS-News: Epigenomics AG / Schlagwort(e): Personalie Epigenomics AG: Jochen Hummel für Heikki Lanckriet in den Aufsichtsrat bestellt ...
Biofrontera Inc. Appoints Heikki Lanckriet to Its Board of ...MarketScreener
in.marketscreener.com
Biofrontera Inc. announced the appointment of Heikki Lanckriet, Ph.D. to its board of directors. Dr. Lanckriet brings to the company more than 20 years of ... Biofrontera Inc. announced the appointment of Heikki Lanckriet, Ph.D. to its board of directors. Dr. Lanckriet brings to the company more than 20 years of ...
People in the News: Heikki Lanckriet, Pilar de la Huerta ...GenomeWeb
www.genomeweb.com
— Heikki Lanckriet, Pilar de la Huerta, Peter Llewellyn-Davis. Sygnis has announced changes to its management team and supervisory board — Heikki Lanckriet, Pilar de la Huerta, Peter Llewellyn-Davis. Sygnis has announced changes to its management team and supervisory board.
Netzwerk-Profile
LinkedIn: Heikki Lanckriet - CEO - Expedeon | LinkedIn - LinkedIn Estonia
View Heikki Lanckriet's profile on LinkedIn, the world's largest professional community. Heikki has 3 jobs listed on their profile. See the complete profile on ...
LinkedIn: heikki Lanckriet - Inhaber - Novexin Ltd | LinkedIn
größten beruflichen Netzwerk. 1 Job Job ist im Profil von heikki Lanckriet
aufgelistet.
LinkedIn: Heikki Lanckriet | Berufsprofil - LinkedIn
Heikki Lanckriets berufliches Profil anzeigen LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Heikki Lanckriet ...
Es fehlt: erftstadt
Interessen
Resignation of Supervisory Board Member Dr Heikki Lanckriet ...markets.businessinsider.com
markets.businessinsider.com
— Berlin, Germany, January 26, – Dr Heikki Lanckriet (PhD) has informed the competent bodies of Epigenomics AG (Frankfurt General Standard: — Berlin, Germany, January 26, – Dr Heikki Lanckriet (PhD) has informed the competent bodies of Epigenomics AG (Frankfurt General Standard: ...
DGAP-News: Expedeon AG: Expedeon AG mandates ODDO SEYDLER BANK AG as...
markets.businessinsider.com
Dr. Heikki Lanckriet, CEO of Expedeon, said: "By mandating a second Designated Sponsor, we want to enhance the continual tradability of our ...
DGAP-News: SYGNIS AG: SYGNIS AG proposes at AGM change of name to...
markets.businessinsider.com
SYGNIS AG Dr. Heikki Lanckriet CEO/CSO Phone: + MC Services AG (Investor Relations ...
Firmen-Mitarbeiter
Board of Directors - BiofronteraBiofrontera US
www.biofrontera-us.com
U.S. BOARD OF DIRECTORS · PROF. HERMANN LUEBBERT, PHD - CHAIRMAN · John J. Borer III · Beth J. Hoffman, Ph.D. · Dr. Heikki Lanckriet · Kevin D. Weber · Contact. U.S. BOARD OF DIRECTORS · PROF. HERMANN LUEBBERT, PHD - CHAIRMAN · John J. Borer III · Beth J. Hoffman, Ph.D. · Dr. Heikki Lanckriet · Kevin D. Weber · Contact.
TeamNeoPhore
www.neophore.com
Robert James. Chairman, NeoPhore ; Pietro Puglisi. Director ; Heikki Lanckriet. Director ; John Haurum. Non-Executive Director ... Robert James. Chairman, NeoPhore ; Pietro Puglisi. Director ; Heikki Lanckriet. Director ; John Haurum. Non-Executive Director ...
Ausbildung
Heikki Lanckriet - Biography
www.marketscreener.com
Heikki Lanckriet founded Expedeon Ltd. and Expedeon Holdings Ltd. Currently, Dr. Lanckriet occupies the position of CEO, Executive Director & Chief Scientific...
Heikki Lanckriet - Biografie
de.marketscreener.com
Founder of Expedeon Ltd. and Expedeon Holdings Ltd., Heikki Lanckriet occupies the position of Chief Executive Officer & Chief Scientific Officer at 4basebio...
Dokumente zum Namen
Heikki LANCKRIET personal appointments - Companies HouseGOV.UK
find-and-update.company-information.service.gov.uk
Heikki LANCKRIET. Filter appointments. Filter appointments. Current appointments. Total number of appointments 6. Date of birth: May NEOPHORE LIMITED ... Heikki LANCKRIET. Filter appointments. Filter appointments. Current appointments. Total number of appointments 6. Date of birth: May NEOPHORE LIMITED ...
4basebio AG reports change in Supervisory Board and new ...4basebioag.com
4basebioag.com
... Heikki Lanckriet and David Roth. For further information, please contact: 4basebio AG Dr. Heikki Lanckriet, Executive Management Board Member Phone: + Heikki Lanckriet and David Roth. For further information, please contact: 4basebio AG Dr. Heikki Lanckriet, Executive Management Board Member Phone: +
Dr. Heikki LanckrietBiofrontera
www.biofrontera.com
Heikki Lanckriet. Occupation: CEO 4basebio PLC, Cambridge, UK. Citizenship: Belgian. Birthplace: Ieper, Belgium. Date of birth: * Professional background ... Heikki Lanckriet. Occupation: CEO 4basebio PLC, Cambridge, UK. Citizenship: Belgian. Birthplace: Ieper, Belgium. Date of birth: * Professional background ...
Innovation in gene synthesis & deliveryAmazon Web Services
wp-4basebio-2020.s3.eu-west-2.amazonaws.com
Heikki Lanckriet, PhD. CEO & CSO. David Roth. CFO. Page Disclaimer. This ... Dr Heikki Lanckriet, 10.2%. Joseph Fernandez, 3.6%. David Roth, 2.5%. Other ... Heikki Lanckriet, PhD. CEO & CSO. David Roth. CFO. Page Disclaimer. This ... Dr Heikki Lanckriet, 10.2%. Joseph Fernandez, 3.6%. David Roth, 2.5%. Other ...
Artikel & Meinungen
Executive Interview - Expedeon - Edison Groupedisongroup.com
www.edisongroup.com
Dr Heikki Lanckriet, CEO of Expedeon, outlines the group's Grow, Buy and Build strategy including recent acquisitions and the group's acquisition criteria. Dr Heikki Lanckriet, CEO of Expedeon, outlines the group's Grow, Buy and Build strategy including recent acquisitions and the group's acquisition criteria.
Wikipedia: 4basebio – Wikipediade.wikipedia.org › wiki
Leitung, Heikki Lanckriet, (2018). David Roth (2018). Mitarbeiterzahl, 89 (2017). Umsatz, 7,8 Mio. Euro (2017). Branche, Pharmazeutik. Website, www.4basebio.com. 4basebio AG (2018 bis Expedeon AG davor Sygnis AG) war ein deutsch-spanischer basebio.com · Sygnis an der Frankfurter Wertpapierbörse ...Es fehlt: Misr Travel Aegyptische Zweigniederlassung Leitung, Heikki Lanckriet, (2018). David Roth (2018). Mitarbeiterzahl, 89 (2017). Umsatz, 7,8 Mio. Euro (2017). Branche, Pharmazeutik. Website, www.4basebio.com. 4basebio AG (2018 bis Expedeon AG davor Sygnis AG) war ein deutsch-spanischer basebio.com · Sygnis an der Frankfurter Wertpapierbörse ... Es fehlt: Misr Travel Aegyptische Zweigniederlassung
Wikipedia: 4basebio – Wikipedia
Leitung, Heikki Lanckriet, (2018). David Roth (2018). Mitarbeiterzahl, 89 (2017). Umsatz, 7,8 Mio. Euro (2017). Branche, Pharmazeutik. Website · Internetseite von Sygnis. Sygnis AG ist ein deutsch-spanischer Polymerasehersteller mit Firmensitzen in Heidelberg und ...
SYGNIS AG: Eine hochsynergetische Übernahme - Vorstandsinterview |...
www.aktien-global.de
Hintergründe und Aktuelles zu Aktien, Börsen und Indizes aus dem Ausland. Zu den abgedeckten Märkten bieten wir Analysen, Hintergründe, Berichterstattung und...
Sonstiges
Biofrontera Inc. Appoints Dr. Heikki Lanckriet to its Board of ...Yahoo Finance
finance.yahoo.com
— ... specializing in the commercialization of dermatologic products, announces the appointment of Heikki Lanckriet, Ph.D. to its Board of Directors — ... specializing in the commercialization of dermatologic products, announces the appointment of Heikki Lanckriet, Ph.D. to its Board of Directors.
Heikki Lanckriet - CEO/Chief Scientific Officer at 4basebioThe Org
theorg.com
CEO/Chief Scientific Officer at 4basebio. Show contact. Org chart. Peers Reports. Peers. HL. Heikki Lanckriet. CEO/Chief Scientific Officer. Reports. CEO/Chief Scientific Officer at 4basebio. Show contact. Org chart. Peers Reports. Peers. HL. Heikki Lanckriet. CEO/Chief Scientific Officer. Reports.
4basebio announces the supply of its opDNA™ DNA ...Yahoo Finance UK
uk.finance.yahoo.com
— 10 April · Dr Heikki Lanckriet, CEO at the Company, commented: · For further enquiries, please contact: · Notes to Editors · About 4basebio — 10 April · Dr Heikki Lanckriet, CEO at the Company, commented: · For further enquiries, please contact: · Notes to Editors · About 4basebio.
Heikki Lanckriet Email and Phone NumberAeroLeads
aeroleads.com
Get Heikki Lanckriet information like Emails, Phone Number, Company, Colleagues, Competitors, Peers, Interests, Skills, Seniority. Get Heikki Lanckriet information like Emails, Phone Number, Company, Colleagues, Competitors, Peers, Interests, Skills, Seniority.
Heikki Lanckriet: Positions, Relations and NetworkMarketScreener
www.marketscreener.com
and Expedeon Holdings Ltd., Heikki Lanckriet presently is CEO, Executive Director & Chief Scientific Officer at 4basebio Plc and Chief Executive Officer & Chief ... and Expedeon Holdings Ltd., Heikki Lanckriet presently is CEO, Executive Director & Chief Scientific Officer at 4basebio Plc and Chief Executive Officer & Chief ...
Historical salary details - Dr. Heikki Lanckriet, PhD, DINTrendlyne.com
trendlyne.com
Dr. Heikki Lanckriet, PhD is the Director of Biofrontera Inc - Warrants ( ). Dr. Heikki Lanckriet, PhD is the Director of Biofrontera Inc - Warrants ( ).
Réseau de Heikki Lanckriet, Analyse des 51 relationsZonebourse
www.zonebourse.com
Identifiez la provenance du réseau de Heikki Lanckriet. Parmis ses 18 postes dont Chief Executive Officer chez 4basebio Plc, il connait directement Identifiez la provenance du réseau de Heikki Lanckriet. Parmis ses 18 postes dont Chief Executive Officer chez 4basebio Plc, il connait directement
Resignation of Supervisory Board Member Dr Heikki Lanckriet ...epigenomics.com
www.epigenomics.com
— Berlin, Germany, January 26, – Dr Heikki Lanckriet (PhD) has informed the competent bodies of Epigenomics AG (Frankfurt General Standard: — Berlin, Germany, January 26, – Dr Heikki Lanckriet (PhD) has informed the competent bodies of Epigenomics AG (Frankfurt General Standard: ...
Biofrontera Inc. Appoints Dr. Heikki Lanckriet to its Board ...SEC.gov
www.sec.gov
... Dr. Heikki Lanckriet to its Board of Directors. WOBURN, Mass. (July 12, 2023) – Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), Dr. Heikki Lanckriet to its Board of Directors. WOBURN, Mass. (July 12, 2023) – Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), ...
Biofrontera Inc. Appoints Dr. Heikki Lanckriet to its Board of ...Baystreet.ca
www.baystreet.ca
— Heikki Lanckriet to its Board of Directors. [ACCESSWIRE]. WOBURN, MA / ACCESSWIRE / July 12, Biofrontera Inc. (Nasdaq:BFRI) — Heikki Lanckriet to its Board of Directors. [ACCESSWIRE]. WOBURN, MA / ACCESSWIRE / July 12, Biofrontera Inc. (Nasdaq:BFRI) ...
Amtsniederlegung des Aufsichtsratsmitglieds Dr. Heikki ...AnlegerPlus
anlegerplus.de
— Heikki Lanckriet (PhD). Berlin, 26. Januar – Dr. Heikki Lanckriet (PhD) hat die zuständigen Gremien der Epigenomics AG (Frankfurt — Heikki Lanckriet (PhD). Berlin, 26. Januar – Dr. Heikki Lanckriet (PhD) hat die zuständigen Gremien der Epigenomics AG (Frankfurt ...
Epigenomics AG: Jochen Hummel appointed to the ...epigenomics.com
www.epigenomics.com
— Heikki Lanckriet, who stepped down from the Board on January 31, For the time being, Mr. Hummel's appointment will end with the Annual — Heikki Lanckriet, who stepped down from the Board on January 31, For the time being, Mr. Hummel's appointment will end with the Annual ...
4BB.UK Company Profile & Executives - 4basebio PLCWSJ
www.wsj.com
Heikki Lanckriet. CEO, Executive Director & Chief Scientific Officer, 4basebio Plc. Heikki Lanckriet founded Expedeon Ltd. and Expedeon Holdings Ltd ... Heikki Lanckriet. CEO, Executive Director & Chief Scientific Officer, 4basebio Plc. Heikki Lanckriet founded Expedeon Ltd. and Expedeon Holdings Ltd ...
4BB.UK | 4basebio PLC Company Profile & ExecutivesWSJ
www.wsj.com
Heikki Lanckriet CEO, Executive Director & Chief Scientific Officer. David John Roth CFO, Secretary & Executive Director. Joseph Manuel Fernández Non ... Heikki Lanckriet CEO, Executive Director & Chief Scientific Officer. David John Roth CFO, Secretary & Executive Director. Joseph Manuel Fernández Non ...
4Basebio CEO and Key Executive Team - Craft.cocraft.co
craft.co
4Basebio's Chairman is Alexander Link. Other executives include David Roth, Chief Financial Officer; Heikki Lanckriet, Chief Executive Officer and 6 others. 4Basebio's Chairman is Alexander Link. Other executives include David Roth, Chief Financial Officer; Heikki Lanckriet, Chief Executive Officer and 6 others.
4Basebio Company Profile - Office Locations, Competitors ...craft.co
craft.co
4Basebio · Alexander Link, Chairman · David Roth, Chief Financial Officer · Heikki Lanckriet, Chief Executive Officer · Rainer Herschlein, Board Member. 4Basebio · Alexander Link, Chairman · David Roth, Chief Financial Officer · Heikki Lanckriet, Chief Executive Officer · Rainer Herschlein, Board Member. 10,20 €
4Basebio plc, Cambridge, United KingdomNorth Data Smart Research
www.northdata.com
Heikki Lanckriet M. del Pilar de la Huerta Hansjörg Plaggemars Hansjoerg Plaggemars David John Roth currently previously. STAY UP TO DATA ... Heikki Lanckriet M. del Pilar de la Huerta Hansjörg Plaggemars Hansjoerg Plaggemars David John Roth currently previously. STAY UP TO DATA ...
4basebio AG gibt Änderungen im Vorstand bekannt2invest AG
2invest-ag.com
Heikki Lanckriet und Herr David Roth und der Vorsitzende des Aufsichtsrates der Gesellschaft Herr Joseph M. Fernández sind heute übereingekommen, dass die ... Heikki Lanckriet und Herr David Roth und der Vorsitzende des Aufsichtsrates der Gesellschaft Herr Joseph M. Fernández sind heute übereingekommen, dass die ...
4basebio Detailed share price data | 4BBMorningstar
tools.morningstar.co.uk
Heikki Lanckriet, PhD | Sale, 45,3222991,418,994, Dr. Heikki Lanckriet, PhD | Exercise of Option, 211, Heikki Lanckriet, PhD | Sale, 45,3222991,418,994, Dr. Heikki Lanckriet, PhD | Exercise of Option, 211,
4basebio Director dealingsThis is Money
investing.thisismoney.co.uk
Trade date, Director, Volume / Price, Trade value, Trade type , Heikki Lanckriet, 29,000 @ p, £120Transfer To. Trade date, Director, Volume / Price, Trade value, Trade type , Heikki Lanckriet, 29,000 @ p, £120Transfer To.
Verwandte Suchanfragen zu Heikki Lanckriet
| John Roth Jochen Hummel Manuel Fernández | Alexander Link |
Personen Vorname "Heikki" (221) Name "Lanckriet" (3) |
sortiert nach Relevanz / Datum